Literature DB >> 15505344

Stem-like cells in human hepatoblastoma.

Henning C Fiegel1, Sylvia Glüer, Beate Roth, Johannes Rischewski, Dietrich von Schweinitz, Benno Ure, Wolfgang Lambrecht, Dietrich Kluth.   

Abstract

Hepatoblastoma is a pediatric liver tumor with epithelial components resembling embryonal and fetal liver cells. The existence of teratoid hepatoblastoma suggests the presence of stem cells in hepatoblastoma. The aim of this study was to analyze the expression of stem cell markers in hepatoblastomas. We studied specimens from 10 hepatoblastomas. Five of the hepatoblastomas were of epithelial and five of mixed type. Immunohistochemistry (IHC) for the stem cell markers CD34, Thy1, c-kit, and the hepatic or biliary lineage markers CK-18, OCH, CK-7, and CD56 was performed. Double IHC for stem cell and lineage markers was used to identify putative liver stem cells. The different markers showed distinct distributions on the tumor cells. Cells in atypical ducts were found to express simultaneously stem cell markers and hepatocytic or biliary lineage markers. Other cells in connective tissue showed c-kit expression, but not hepatic or biliary marker expression. The data show the presence of different cell populations bearing stem cell markers in human hepatoblastoma. Ductal cells co-expressing stem cell markers and hepatic lineage markers phenotypically resemble hepatic stem-like cells. These findings support the thesis that stem cells play a role in the histogenesis of hepatoblastoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505344      PMCID: PMC3957818          DOI: 10.1369/jhc.4A6297.2004

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  24 in total

Review 1.  Hepatic stem cells in liver regeneration.

Authors:  S S Thorgeirsson
Journal:  FASEB J       Date:  1996-09       Impact factor: 5.191

Review 2.  Pluripotential liver stem cells: facultative stem cells located in the biliary tree.

Authors:  M R Alison; M H Golding; C E Sarraf
Journal:  Cell Prolif       Date:  1996-07       Impact factor: 6.831

3.  Hepatoblastoma: an immunohistochemical and ultrastructural study.

Authors:  P Abenoza; J C Manivel; M R Wick; K Hagen; L P Dehner
Journal:  Hum Pathol       Date:  1987-10       Impact factor: 3.466

4.  Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases.

Authors:  K G Ishak; P R Glunz
Journal:  Cancer       Date:  1967-03       Impact factor: 6.860

5.  Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6.

Authors:  P Ruck; J C Xiao; T Pietsch; D Von Schweinitz; E Kaiserling
Journal:  Histopathology       Date:  1997-10       Impact factor: 5.087

6.  Small epithelial cells and the histogenesis of hepatoblastoma. Electron microscopic, immunoelectron microscopic, and immunohistochemical findings.

Authors:  P Ruck; J C Xiao; E Kaiserling
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  Association of thy-1 cell surface differentiation antigen with certain connective tissues in vivo.

Authors:  R J Morris; M A Ritter
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

8.  Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver.

Authors:  H A Crosby; S G Hubscher; R E Joplin; D A Kelly; A J Strain
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

9.  'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver.

Authors:  T Roskams; R De Vos; V Desmet
Journal:  Histopathology       Date:  1996-04       Impact factor: 5.087

10.  Identification of bipotential progenitor cells in human liver development.

Authors:  Y Haruna; K Saito; S Spaulding; M A Nalesnik; M A Gerber
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  13 in total

Review 1.  Liver cancer: the role of stem cells.

Authors:  M R Alison; M J Lovell
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

2.  β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.

Authors:  Sharada Mokkapati; Katharina Niopek; Le Huang; Kegan J Cunniff; E Cristy Ruteshouser; Mark deCaestecker; Milton J Finegold; Vicki Huff
Journal:  Cancer Res       Date:  2014-05-21       Impact factor: 12.701

Review 3.  'Teratoid' Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma.

Authors:  Consolato M Sergi; Marta Rojas-Vasquez; Michelle Noga; Bryan Dicken
Journal:  Children (Basel)       Date:  2022-04-15

Review 4.  Stem cell origins and animal models of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli; Clifford J Steer; M Behnan Sahin; Erik N K Cressman
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

5.  Gastrointestinal stromal tumor of the lesser omentum in a young adult patient with a history of hepatoblastoma: report of a case.

Authors:  Ryuusuke Aihara; Tetsuro Ohno; Erito Mochiki; Kana Saito; Shinji Sakurai; Atsushi Takahashi; Takayuki Asao; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2009-03-25       Impact factor: 2.549

6.  Cytokeratin 20-positive hepatocellular carcinoma.

Authors:  D Fanni; S Nemolato; R Ganga; G Senes; C Gerosa; P Van Eyken; K Geboes; G Faa
Journal:  Eur J Histochem       Date:  2009-12-29       Impact factor: 3.188

Review 7.  Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma.

Authors:  Anna Alisi; William C Cho; Franco Locatelli; Doriana Fruci
Journal:  Int J Mol Sci       Date:  2013-12-18       Impact factor: 5.923

8.  C-KIT-positive undifferentiated tumor of the liver: A case report.

Authors:  Hyun Hee Chu; Baik Hwan Cho; Ji Soo Song; Kyung Mi Kim; Woo Sung Moon
Journal:  Oncol Lett       Date:  2014-07-08       Impact factor: 2.967

Review 9.  Progress in stem cell-derived technologies for hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  Stem Cells Cloning       Date:  2010-05-03

10.  Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells.

Authors:  Nirmala Mavila; David James; Sarah Utley; Nguyen Cu; Orly Coblens; Katrina Mak; C Bart Rountree; Michael Kahn; Kasper S Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.